168 related articles for article (PubMed ID: 9704164)
1. The efficacy and use of anticonvulsants in mood disorders.
Dunn RT; Frye MS; Kimbrell TA; Denicoff KD; Leverich GS; Post RM
Clin Neuropharmacol; 1998; 21(4):215-35. PubMed ID: 9704164
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsants in affective disorders.
Small JG
Psychopharmacol Bull; 1990; 26(1):25-36. PubMed ID: 2196624
[TBL] [Abstract][Full Text] [Related]
3. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
Rajna P
Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
[TBL] [Abstract][Full Text] [Related]
4. Beyond lithium in the treatment of bipolar illness.
Post RM; Frye MA; Denicoff KD; Leverich GS; Kimbrell TA; Dunn RT
Neuropsychopharmacology; 1998 Sep; 19(3):206-19. PubMed ID: 9653709
[TBL] [Abstract][Full Text] [Related]
5. Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Gross R; Grunhaus L
South Med J; 1995 Feb; 88(2):249-50. PubMed ID: 7839179
[No Abstract] [Full Text] [Related]
6. Mood stabilizers in children and adolescents.
Ryan ND; Bhatara VS; Perel JM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):529-36. PubMed ID: 10230184
[TBL] [Abstract][Full Text] [Related]
7. [Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
Okuma T
Seishin Shinkeigaku Zasshi; 2005; 107(5):415-22. PubMed ID: 15981617
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
Evins AE
J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
[TBL] [Abstract][Full Text] [Related]
9. The place of anticonvulsant therapy in bipolar illness.
Post RM; Ketter TA; Denicoff K; Pazzaglia PJ; Leverich GS; Marangell LB; Callahan AM; George MS; Frye MA
Psychopharmacology (Berl); 1996 Nov; 128(2):115-29. PubMed ID: 8956373
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant efficacy of valproate-like carboxylic acids: a potential target for anti-bipolar therapy.
Azab AN; Greenberg ML
Bipolar Disord; 2007 May; 9(3):197-205. PubMed ID: 17430293
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of atypical antipsychotics in mood disorders.
Yatham LN
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S9-14. PubMed ID: 12832944
[TBL] [Abstract][Full Text] [Related]
12. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
13. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs: indications other than epilepsy.
Spina E; Perugi G
Epileptic Disord; 2004 Jun; 6(2):57-75. PubMed ID: 15246950
[TBL] [Abstract][Full Text] [Related]
15. New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.
Bowden CL
Neuropsychopharmacology; 1998 Sep; 19(3):194-9. PubMed ID: 9653707
[TBL] [Abstract][Full Text] [Related]
16. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
17. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
18. [Use of antiepileptic drugs in bipolar disorder].
Pérez-Ceballos MA; Vega-Gil N; Sánchez MB; Armijo JA
Actas Esp Psiquiatr; 2006; 34(1):55-64. PubMed ID: 16525906
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic effects of antiepileptic drugs.
Ettinger AB
Neurology; 2006 Dec; 67(11):1916-25. PubMed ID: 17159095
[TBL] [Abstract][Full Text] [Related]
20. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.
Mula M; Pini S; Cassano GB
J Clin Psychopharmacol; 2007 Jun; 27(3):263-72. PubMed ID: 17502773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
